Highlights. WHO has accepted the recommendation from the Solidarity Trial’s International Steering Committee to discontinue the trial’s hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19. WHO Regional Director for the Western Pacific, Dr Takeshi Kasai spoke of a ‘new normal’, one….
